Alnylam Gives Sneak Peek of Hypercholesterolemia Program at OTS Meeting; Additional Work Underway

Alnylam Gives Sneak Peek of Hypercholesterolemia Program at OTS Meeting; Additional Work Underway
By Doug Macron
October 26, 2006
RNAi News
At the meeting, an Alnylam researcher presented some early-stage results from the company?s program targeting PCSK9, a protease that degrades the LDL receptor, being conducted with the University of Texas Southwestern Medical Center.
Paid subscription is required to view article.
Comments: 0
Votes:27